OX40 has been previously shown to expand Tregs in vivo, as a potential therapeutic for autoimmune disease, however, Tregs expanded by this mechanism have been shown to exhibit impaired suppressive function due to exhaustion33. Here, TNFRSF4 is linked to autoimmune disease.